Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Asset Utilization Ratio (2016 - 2025)

Guided Therapeutics' Asset Utilization Ratio history spans 14 years, with the latest figure at 0.69 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 12825.2% to 0.69 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.69, a 12825.2% increase, with the full-year FY2025 number at 0.57, up 12256.19% from a year prior.
  • Asset Utilization Ratio hit 0.69 in Q4 2025 for Guided Therapeutics, up from 0.19 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for GTHP hit a ceiling of 0.69 in Q4 2025 and a floor of 0.0 in Q1 2025.
  • Historically, Asset Utilization Ratio has averaged 0.08 across 5 years, with a median of 0.04 in 2022.
  • The widest YoY moves for Asset Utilization Ratio: up 12825.2% in 2025, down 98.36% in 2025.
  • Tracing GTHP's Asset Utilization Ratio over 5 years: stood at 0.04 in 2021, then plummeted by 91.61% to 0.0 in 2022, then soared by 1438.52% to 0.06 in 2023, then crashed by 90.36% to 0.01 in 2024, then surged by 12825.2% to 0.69 in 2025.
  • Business Quant data shows Asset Utilization Ratio for GTHP at 0.69 in Q4 2025, 0.19 in Q3 2025, and 0.12 in Q2 2025.